DESCRIPTION:
Trimetazidine Dihydrochloride Tablets
Trimetazidine is a unique antianginal and anti-ischemic agent belonging to a new class of compounds that display anti-ischemic effects without inducing homodynamic changes and improve the status of the ischemic myocardium.
 

COMPOSITION :
Each film-coated tablet contains Trimetazidine dihydrochloride 20 mg.

      For more information, please see Full Prescribing Information.

INDICATIONS:
Trimetazidine is indicated for:
--Ischemic heart disease (angina pectoris, sequelae of infarction)
--Adjuvant symptomatic treatment of vertigo and tinnitus
Hypersensitivity to one of the components.

DOSAGE & ADMINISTRATION :
One tablet twice or thrice daily at mealtimes.

Product Enquiry	Product Quotation	Sample Request	Order Now
Information about Generic Medicines      Information about Manufacturing

Select Language English Russian French German Italian Japanese Korean Portuguese Spanish Greek Dutch Hindi



            
 Print page   Send by mail